Obesity, acanthosis nigricans, insulin resistance, and hyperandrogenemia: pediatric perspective and natural history
- PMID: 2933497
- DOI: 10.1016/s0022-3476(85)80182-7
Obesity, acanthosis nigricans, insulin resistance, and hyperandrogenemia: pediatric perspective and natural history
Abstract
We studied the syndrome of acanthosis nigricans, obesity, insulin resistance, and hyperandrogenemia in 22 patients. Although isolated case reports in adolescents have appeared, this syndrome has not received full recognition as a pediatric entity. Our patients (17 girls, five boys) had a mean weight 5.7 SD above the mean for age, although mean height was only 0.5 SD above the mean for age. All patients had acanthosis nigricans. Their insulin resistance was significantly greater than that in a control group with comparable obesity. Fasting insulin concentration was 5.25 microU/ml in lean controls, 19.6 microU/ml in obese controls, and 49.8 microU/ml in study patients (P less than 0.002). Mean glucose disappearance rate during an insulin tolerance test was 6.7%/min in lean controls, 5.19%/min in obese controls, and 2.35%/min in study patients (P less than 0.02). After menarche, mean plasma testosterone concentration was 106 ng/dl, compared with less than 50 ng/dl in all lean and obese control patients. Data derived from our series of patients lead us to conclude that (1) this is a genetic syndrome, although the exact mode of inheritance is unclear; (2) the natural history of the syndrome invariably begins with the onset of obesity, followed by acanthosis nigricans that worsens with progressive weight gain; (3) acanthosis nigricans is thus a marker for hyperinsulinemia, which occurs before hyperandrogenemia; (4) hyperandrogenemia occurs only after menarche. Identification of this syndrome should permit monitoring for the development of hyperandrogenemia during puberty and determination of other affected family members.
Similar articles
-
The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans.J Clin Endocrinol Metab. 1987 Jan;64(1):180-4. doi: 10.1210/jcem-64-1-180. J Clin Endocrinol Metab. 1987. PMID: 2946716
-
The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.J Clin Endocrinol Metab. 1988 Jan;66(1):131-9. doi: 10.1210/jcem-66-1-131. J Clin Endocrinol Metab. 1988. PMID: 2961783
-
The autosomal dominant trait of obesity, acanthosis nigricans, hypertension, ischemic heart disease and diabetes type 2.Horm Res. 2001;55(6):298-304. doi: 10.1159/000050017. Horm Res. 2001. PMID: 11805435
-
[HAIR-AN syndrome].Nihon Rinsho. 1994 Oct;52(10):2648-52. Nihon Rinsho. 1994. PMID: 7983793 Review. Japanese.
-
Hyperandrogenism, insulin resistance, and acanthosis nigricans syndrome: a common endocrinopathy with distinct pathophysiologic features.Am J Obstet Gynecol. 1983 Sep 1;147(1):90-101. doi: 10.1016/0002-9378(83)90091-1. Am J Obstet Gynecol. 1983. PMID: 6351620 Review.
Cited by
-
Social anxiety, depression and self-esteem in obese adolescent girls with acanthosis nigricans.J Clin Res Pediatr Endocrinol. 2015 Mar;7(1):63-8. doi: 10.4274/jcrpe.1515. J Clin Res Pediatr Endocrinol. 2015. PMID: 25800478 Free PMC article.
-
State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS).Int J Pediatr Endocrinol. 2011 Aug 26;2011(1):9. doi: 10.1186/1687-9856-2011-9. Int J Pediatr Endocrinol. 2011. PMID: 21899727 Free PMC article.
-
Endothelial dysfunction in obese non-hypertensive children without evidence of sleep disordered breathing.BMC Pediatr. 2010 Feb 15;10:8. doi: 10.1186/1471-2431-10-8. BMC Pediatr. 2010. PMID: 20156343 Free PMC article.
-
How possible is the prevention of polycystic ovary syndrome development in adolescent patients with early onset of hyperandrogenism.J Endocrinol Invest. 1998 Oct;21(9):613-7. doi: 10.1007/BF03350786. J Endocrinol Invest. 1998. PMID: 9856415 Review.
-
Severe Insulin Resistance Syndromes: Clinical Spectrum and Management.Int J Mol Sci. 2025 Jun 13;26(12):5669. doi: 10.3390/ijms26125669. Int J Mol Sci. 2025. PMID: 40565151 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical